ClinicalTrials.gg
Not yet recruitingNCT07210489IMAGERIEMOTRUpdated Sep 21, 2026

Therapeutic Benefits of a Motor Imaging Protocol Following Anterior Cruciate Ligament Reconstruction Surgery

An interventional study of Reconstructive surgery after anterior cruciate ligament rupture and sessions from a physical therapist in Anterior Cruciate Ligament Tear, sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. Not yet recruiting at 1 site in France. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche · Not applicable, Interventional, and Supportive care

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-15

Among 46 studies in Anterior Cruciate Ligament Injuries with a site in France — 17 open to participants now, 18 under way, none of them phase 3. Anterior Cruciate Ligament Injuries · France.

Planned enrollment
16th of 29
70 · median 75
Started
2026
with 5 others
No phase
29 of 46
12 open now
Primary completion
2028-03
later than 11 of 17 live
Registered
42nd of 46
by date
Lead sponsor
8 of 46
GCS Ramsay Santé pour l'Enseignement et la Recherche

Among the 46 studies in Anterior Cruciate Ligament Injuries with a site in France, this one is the 16th largest by planned enrollment of the 29 interventional ones that give a count, is one of 6 that started in 2026, is one of 29 with no phase, reaches primary completion later than 11 of the 17 other live ones, and was the 42nd registered.

Anterior Cruciate Ligament Injuries

625 studies on the registry are indexed under Anterior Cruciate Ligament Injuries; 192 are open to participants now.

Browse Anterior Cruciate Ligament Injuries studies →

Open to participants now

17 of the 46 studies in Anterior Cruciate Ligament Injuries with a site in France are open now. Recruiting first, the newest first:

11 more — sign in →

All 17 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 122 Anterior Cruciate Ligament Injuries studies recruiting now, 27 (22%) set no upper age limit and 92 (75%) stop at 75 or younger; 46 take children under 18; 21 take healthy volunteers.

This study: 18 Years to 45 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 46 studies in Anterior Cruciate Ligament Injuries with a site in France, or all of them as a file.
02

Study summary

The purpose of this study is to compare changes in lower limb symmetry during functional and strength tests, before and after the motor imagery program, in patients who received the 3-week motor imagery program starting 3 months post-surgery versus patients who did not receive the motor imagery program.

Read the detailed description

This is a prospective, comparative, randomized, controlled, single-blind (patient), single-center study evaluating the effects of a motor imagery program in parallel with rehabilitation sessions in patients who have had an anterior cruciate ligament rupture.

The study population is composed of adult patients who underwent reconstructive surgery after anterior cruciate ligament rupture, followed up at the Clinique de la Sauvegarde in Lyon for post-operative functional and strength testing of the anterior cruciate ligament.

Patients included in the study will be randomized into two study arms (experimental arm and control arm).

03

Conditions studied

  • Anterior Cruciate Ligament Tear
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18 to 45;
  • Individuals who have undergone anterior cruciate ligament reconstruction for the first time on the operated leg;
  • Patients able to understand and read French;
  • Affiliation with a social insurance plan;
  • Signed .

Exclusion criteria

Exclusion Criteria:

  • Recurrence or rupture of the contralateral anterior cruciate ligament;
  • History of another orthopedic surgery on the ipsilateral and/or contralateral lower limb;
  • History of an injury to the ipsilateral and/or contralateral lower limb within the last 3 months;
  • Osteotomy;
  • Cognitive disorders observed by the investigator for inclusion ;
  • Vestibular disorders known to the patient or observed by the investigator for inclusion;
  • Post-surgical complications (infection, early graft rupture);
  • Patient participating in another interventional clinical trial, or in a period of exclusion from another interventional study;
  • Patient under guardianship or conservatorship;
  • Pregnant or breastfeeding women.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Motor imagery program

    Patients will receive rehabilitation sessions from a physical therapist in accordance with standard practice and will be asked to complete a 3-week motor imagery program starting 3 months after anterior cruciate ligament surgery.

    Procedure: Reconstructive surgery after anterior cruciate ligament rupture · Other: sessions from a physical therapist

  • Active comparator
    Cognitive (non-motor) task program

    Patients will receive rehabilitation sessions from a physical therapist in accordance with standard practice and will be asked to complete a 3-week cognitive (non-motor) task program starting 3 months after anterior cruciate ligament surgery.

    Procedure: Reconstructive surgery after anterior cruciate ligament rupture · Other: sessions from a physical therapist

Interventions

  • ProcedureReconstructive surgery after anterior cruciate ligament rupture

    surgical technique for repairing the cruciate ligament

  • Othersessions from a physical therapist

    sessions from a physical therapist in accordance with standard practice

06

What researchers measure

Primary outcomes

  1. Evolution of limb symmetry

    Evolution of limb symmetry assessed by the Limb Symmetry Index in %

    Time frame: between 3 and 4.5 months

  2. Isometric quadriceps strength

    Isometric quadriceps strength using a Micro Fet handheld dynamometer (in Newtons)

    Time frame: between 3 and 4.5 months

  3. Isometric hamstring strength

    Isometric hamstring strength measured using a Micro Fet handheld dynamometer (in Newtons)

    Time frame: between 3 and 4.5 months

  4. Average concentric strength

    Average concentric strength during a counter-movement jump measured using a force platform (in Newtons)

    Time frame: between 3 and 4.5 months

  5. Average strength

    Average strength during a squat measured using a force platform (in Newtons)

    Time frame: between 3 and 4.5 months

  6. Quadriceps activation measured

    Quadriceps activation measured using electromyography

    Time frame: between 3 and 4.5 months

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Mar 2028, 17 months later.

Of 278 non-industry interventional studies with no phase under Anterior Cruciate Ligament Injuries, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 70. This study's planned 17 months is below that.

Counting every sponsor, half of 287 studies reached it within 30 months; a quarter within 14 and three quarters within 70.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 19, 2025
First posted
Oct 7, 2025
StartEst.
Oct 2026
Primary completionEst.
Mar 2028
CompletionEst.
Mar 2028
Last update
Sep 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07210489
Collaborators
Euraxi Pharma
Responsible party
Sponsor
First posted
Oct 7, 2025
Start date
Oct 2026 (estimated)
Primary completion
Mar 2028 (estimated)
Completion
Mar 2028 (estimated)
Last update
Sep 21, 2026

Study contacts

Benoit PAIROT DE FONTENAY
Contact
benoit.pdf@gmx.com
601740875 ext. +33

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion